GlassScriptPhysician profile
Michael H Hines
NPI 1205947397
$5,145.90
in general payments reported to CMS, 2019-2025
19 companies · $952 in 2025
The $952 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $3,479 · 2023: $477 · 2024: $86.54 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835 · Travel and Lodging: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.15 |
| Travel and Lodging | $680.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,876.94 | 2022 | |
| Intuitive Surgical, INC. | $951.32 | 2022 | |
| Getinge USA Sales, LLC | $871.52 | 2021-2025 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Kls-Martin L.P. | $833.41 | 2022-2023 | |
| Edwards Lifesciences Corporation | $164.98 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $93.82 | 2021-2023 | Xarelto |
| Abiomed | $50.37 | 2025 | |
| Medtronic, INC. | $47.41 | 2023-2025 | Endurant Iis |
| Solventum Corporation | $46.19 | 2024-2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Endologix LLC | $37.90 | 2021-2023 | Ovation Ix Iliac Stent Graft |
| Calliditas Therapeutics US INC. | $31.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.49 | 2021 | |
| Amgen INC. | $19.24 | 2024 | Krystexxa |
| W. L. Gore & Associates, INC. | $19.01 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Bayer Healthcare Pharmaceuticals INC. | $17.54 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.59 | 2022 | |
| Horizon Therapeutics Plc | $15.39 | 2023 | Krystexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.28 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.